| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA70273
Max Phase: Preclinical
Molecular Formula: C16H15N5O
Molecular Weight: 293.33
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: NCc1nc2cc(NC(=O)/C=C/c3cccnc3)ccc2[nH]1
Standard InChI: InChI=1S/C16H15N5O/c17-9-15-20-13-5-4-12(8-14(13)21-15)19-16(22)6-3-11-2-1-7-18-10-11/h1-8,10H,9,17H2,(H,19,22)(H,20,21)/b6-3+
Standard InChI Key: WAPNSMQJTRIQBA-ZZXKWVIFSA-N
Associated Targets(non-human)
Matrix metalloproteinase 9 44 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 293.33 | Molecular Weight (Monoisotopic): 293.1277 | AlogP: 2.07 | #Rotatable Bonds: 4 |
| Polar Surface Area: 96.69 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.52 | CX Basic pKa: 7.90 | CX LogP: 0.84 | CX LogD: 0.22 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.64 | Np Likeness Score: -1.58 |
References
| 1. Wang X, Choe Y, Craik CS, Ellman JA.. (2002) Design and synthesis of novel inhibitors of gelatinase B., 12 (16): [PMID:12127537] [10.1016/s0960-894x(02)00365-7] |
Source
Source(1):